Associate Professor of Medicine, University of Chicago
Hematology
Dr. Andrew S. Artz, MD
|
|
Give Review
Andrew S. Artz practices Hematology. He went to medical school at West Virginia University School of Medicine. He received awards:"Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Dr. Andrew S. Artz is a published MD. He has 46 publications published. The most current publication "Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes." He accepts all Medicare patients.
Publications
- Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic Syndromes.
- Correspondence Regarding the Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.
- Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation.
- Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor Cells from unrelated donors, a Center for Inter...
- A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained Anemia and serum ferritin 20-200 ng/mL.
- Unexplained anaemia in the elderly is characterised by features of low grade inflammation.
- Geriatric assessment to predict survival in older allogeneic hematopoietic Celltransplantation recipients.
- Clofarabine-associated Acute kidney injury in patients undergoing hematopoietic stem cell transplant.
- Allotransplantation for patients age 40 years and greater with non-Hodgkin Lymphoma (NHL): encouraging progression-free survival.
- A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory Leukemia and high-risk myelodysplastic syndromes.
- Treatments of Disease relapse after allogeneic stem cell transplantation focusing on donor lymphocyte infusion.
- Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhi...
- Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
- Microchimerism and allogeneic transplantation: We need the proof in the pudding.
- Pre-transplant serum ferritin is prognostic but is it useful?
- Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?
- Pilot Study of Comprehensive Geriatric Assessment (CGA) in Allogeneic Transplant: CGA Captures a High Prevalence of Vulnerabilities in Older Transplant Recipients.
- Umbilical Cord Blood Transplantation Supported by Third-Party Donor Cells: Rationale, Results, and Applications.
- Influence of related donor age on outcomes after peripheral blood stem Cell transplantation.
- From biology to clinical practice: aging and hematopoietic Cell transplantation.
- Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic Cell transplantation.
- Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid enGraftment, low GVHD, and durable remissions.
- Allogeneic stem cell transplant in renal failure: enGraftment and prolonged survival, but high incidence of neurologic toxicity.
- Classifying Cytogenetics in Patients with AML in Complete Remission Undergoing Allogeneic Transplantation: A CIBMTR Study.
- Unexplained Anemia Predominates Despite an Intensive Evaluation in a Racially Diverse Cohort of Older Adults From a Referral Anemia Clinic.
- Implementing a geriatric assessment in cooperative group clinical Cancer trials: CALGB 360401.
- Gene mutations, epigenetic dysregulation, and personalized therapy in Myeloid neoplasia: are we there yet?
- T-cell-depleted reduced-intensity conditioning transplantation for Lymphoma: do donor lymphocyte infusions really matter?
- American Society of Clinical Oncology provisional clinical opinion: Chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for trea...
- Blood stem Cell transplantation in older patients.
- BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem Cell transplants.
- Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor Cell mobilization by filgrastim: results of an open-label trial in normal donors.
- Diminished quality of life and physical function in community-dwelling elderly with Anemia.
- Immunity from smallpox vaccine persists for decades: a longitudinal study.
- Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic Cell transplantation.
- Variation in supportive care practices in hematopoietic Cell transplantation.
- Anemia and the frail elderly.
- Hematopoiesis is not clonal in healthy elderly women.
- Individual physician practice variation in hematopoietic Cell transplantation.
- Prevalence of Anemia in the nursing home: contribution of chronic kidney disease.
- Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic Cell transplantation.
- Issues of aging and geriatric medicine: relevance to Cancer treatment and hematopoietic reconstitution.
- Serum erythropoietin and aging: a longitudinal analysis.
- Mechanisms of unexplained Anemia in the nursing home.
- Pneumococcal vaccination and revaccination of older adults.
Schools
Wv Univ Sch Of Med
Georgetown University Hospital
University Of Chicago Hosps
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Bladder Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Chicago -
Georgetown University Hospital -
West Virginia University School of Medicine
Hospital
-
University of Chicago Medical Center
Drug Facts
| NPI NUMBER | 1306859772 | |
| NPPES Provider LastName | ARTZ | |
| NPPES Provider FirstName | ANDREW | |
| NPPES Provider ZIPCode | 606371447 | |
| NPPES Provider State | IL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 157.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1306859772 |
| Last Name Of The Provider | ARTZ |
| First Name Of The Provider | ANDREW |
| View All |
Similar Doctors
|
|
Dr. Timothy M. Kuzel, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Regina M. Stein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Halla S. Nimeiri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. VanDerweele, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paramjeet G. Khosla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacqueline Garcia, MD |
|
|
Dr. Phillip C. Hoffman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gladell Paner, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jamile M. Shammo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith L. Wright, MD |
|
|
Dr. Rachel L. Mitchell, MD |
|
|
Dr. Hiral A. Shah, MD |
|
|
Dr. Kamran Rashid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nilay A. Shah, MD |